Prudential Financial’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.8K | Buy |
+14,865
| New | +$35.8K | ﹤0.01% | 2364 |
|
|
2025
Q1 | – | Sell |
-591,505
| Closed | -$3.22M | – | 2347 |
|
|
2024
Q4 | $3.22M | Sell |
591,505
-52,600
| -8% | -$287K | ﹤0.01% | 1067 |
|
|
2024
Q3 | $5.35M | Buy |
644,105
+46,223
| +8% | +$384K | 0.01% | 967 |
|
|
2024
Q2 | $4.28M | Buy |
+597,882
| New | +$4.28M | 0.01% | 999 |
|
|
2024
Q1 | – | Sell |
-269,608
| Closed | -$1.77M | – | 2723 |
|
|
2023
Q4 | $1.77M | Buy |
269,608
+54,713
| +25% | +$358K | ﹤0.01% | 1517 |
|
|
2023
Q3 | $2.06M | Buy |
214,895
+289
| +0.1% | +$2.78K | ﹤0.01% | 1342 |
|
|
2023
Q2 | $2.67M | Sell |
214,606
-11,287
| -5% | -$140K | ﹤0.01% | 1231 |
|
|
2023
Q1 | $3.16M | Buy |
225,893
+46,135
| +26% | +$646K | 0.01% | 1063 |
|
|
2022
Q4 | $2.57M | Buy |
179,758
+168,699
| +1,525% | +$2.41M | ﹤0.01% | 1177 |
|
|
2022
Q3 | $282K | Sell |
11,059
-1,226,043
| -99% | -$31.3M | ﹤0.01% | 2333 |
|
|
2022
Q2 | $35.1M | Buy |
1,237,102
+737,313
| +148% | +$20.9M | 0.06% | 318 |
|
|
2022
Q1 | $17.6M | Buy |
499,789
+484,257
| +3,118% | +$17.1M | 0.02% | 534 |
|
|
2021
Q4 | $652K | Buy |
+15,532
| New | +$652K | ﹤0.01% | 2097 |
|